Rosacea’s Hidden Fungal Problem: A New Study Maps the Skin Microbiome Like Never Before

Rosacea affects roughly 5.46% of adults worldwide, yet the biological mechanisms behind its chronic flushing, redness, and skin lesions remain stubbornly unclear. Most microbiome research on the condition has zeroed in on bacteria, but a new pilot study by Tang, Shen, Li, and Yuan published in June 2026 takes a different approach: mapping both the bacterial and fungal communities on facial skin at the same time, and tracking how skin oil content shapes what lives there. The findings are preliminary, but they point toward the fungi as a potentially underappreciated driver of rosacea inflammation.

Fungal communities in rosacea show near-complete species replacement

The most striking result in the study is how dramatically the fungal landscape shifts in rosacea. Healthy controls maintained a relatively stable fungal community with a Shannon diversity index of 2.13, while the single severe rosacea case dropped to 1.28. More telling was the beta diversity picture: fungal communities in rosacea samples registered Bray-Curtis dissimilarity values approaching 1.0, meaning the species composition was almost entirely different from that seen in healthy skin. Bacterial communities showed clear separation too, with the first principal coordinate explaining 69.1% of the variance, but the statistical signal for fungi was sharper. PERMANOVA analysis put fungal dysbiosis at R2 = 0.407 with a significant p-value of 0.035, while the bacterial equivalent did not reach significance (R2 = 0.375, p = 0.277).

This pattern aligns with other work finding elevated fungal genera in rosacea skin samples, reinforcing the case that the mycobiome deserves more attention than it typically receives in dermatology research. Malassezia, a lipid-dependent yeast genus already linked to seborrheic dermatitis and dandruff, dominated fungal communities across most samples but showed extreme polarization: its relative abundance swung wildly between healthy and rosacea skin. Environmental fungi such as Chaetomium and Aspergillus, which rarely colonize healthy facial skin, appeared in rosacea samples, suggesting that whatever normally keeps opportunistic species out is compromised.

Why fungal dysbiosis may worsen rosacea's inflammatory cycle

The mechanistic path from fungal imbalance to facial inflammation runs through the immune system's pattern-recognition machinery. Fungal cell wall components, particularly beta-glucans and mannans, activate pattern recognition receptors including Dectin-1, Dectin-2, and TLR2 on immune cells. That activation triggers a cascade of proinflammatory cytokine release. Malassezia species add a further wrinkle by producing lipases that break down sebum into free fatty acids, compounds known to irritate and inflame skin. Given that global rosacea prevalence sits at around 5.46% of adults, predominantly in the 45-60 age group, even modest mechanistic clarity about what sustains the condition could translate into meaningful treatment advances for millions of people.

The bacterial side of the equation is not irrelevant. Rosacea patients showed higher bacterial diversity overall (Shannon index: 2.26 versus 0.71 in healthy controls), with three bacterial lineages expanding more than tenfold: Peptoniphilus (ZOTU_3), an unclassified taxon (ZOTU_5), and Acinetobacter (ZOTU_6). A prior case-control study documented distinct rosacea-associated bacterial shifts including depletion of Roseomonas mucosa and enrichment of Campylobacter ureolyticus. The current study builds on that picture, but the authors note that cross-kingdom correlations between bacteria and fungi were weak and nonsignificant (all p > 0.05), meaning the two microbial kingdoms appear to be operating somewhat independently in rosacea-affected skin, at least in this small dataset.

How the team profiled both bacterial and fungal communities

The study enrolled eight participants: six with rosacea (one severe, five moderate) and two healthy controls. Facial skin swabs were processed for 16S rRNA gene sequencing to profile bacteria and ITS amplicon sequencing for fungi, two complementary culture-independent methods that have become the standard toolkit for characterizing skin microbial communities. Participants were also stratified by skin oil content into three groups: excessive oil (n=2), oily (n=3), and minimal oil (n=3). That stratification turned out to matter: oily skin harbored the highest bacterial and fungal diversity of any group, with bacterial Shannon scores averaging 2.51 and richness reaching 412 OTUs. The authors suggest this hyperdiversity may partly reflect disruption by Demodex mites, which are nine times more common in rosacea patients and carry endosymbiotic bacteria that can spill into the skin environment when mite populations are disturbed.

It is worth being explicit about the limitations common to pilot microbiome studies of this kind: small sample sizes limit statistical power, and cross-sectional designs cannot determine whether microbial shifts cause rosacea or result from it. The study's own authors flag that Demodex mite counts were not directly assessed, a notable gap given the mite's mechanistic importance. Functional profiling through metagenomics or metabolomics was also absent, so the study describes who is present without fully explaining what they are doing.

Open questions about causality and the role of skin oil

Skin oil content emerging as a primary determinant of microbial diversity raises a chicken-and-egg problem. Rosacea can alter sebaceous gland activity, which changes the fatty acid environment, which in turn shapes which microbes can thrive. Disentangling that loop requires longitudinal data and larger cohorts. The study also could not resolve whether the environmental fungi appearing in rosacea skin represent transient contamination or true colonization, a distinction with real therapeutic implications. If colonization resistance is genuinely impaired in rosacea skin, antifungal strategies might be worth exploring alongside existing antibiotic-based treatments like doxycycline.

What microbiome-targeted rosacea treatments could come next

The study points toward several possible therapeutic directions, though all remain early-stage. Oral tetracyclines, already used for rosacea, may owe some of their efficacy to microbiome modulation rather than pure antibacterial action. Probiotics featuring Roseomonas mucosa or Staphylococcus epidermidis have shown early promise in restoring a more balanced skin microbiome. Emerging microbiome therapies including live biotherapeutic products and skin microbiota transplantation represent a longer-horizon possibility for restoring microbial balance in inflammatory skin conditions. The dual-kingdom picture this study provides, however incomplete, is a necessary foundation for any of those approaches to be designed rationally. The fungi, it turns out, may have been hiding in plain sight all along.

Evidence rating

INVESTIGATIONAL — 55/100

Caveats:

• Pilot study with only 8 participants (6 rosacea, 2 controls) — far too small to draw reliable conclusions.
• Cross-sectional design: shows association only, cannot establish cause or direction of effect.
• No Demodex mite assessment, despite its known central role in rosacea pathogenesis.
• No functional profiling (metabolomics, metagenomics) to explain mechanisms behind observed community shifts.
• Findings have not been replicated in any independent cohort.

Prospective observational pilot study (n=8) comparing facial skin bacterial and fungal communities in rosacea patients versus healthy controls using 16S rRNA and ITS sequencing. The extremely small sample — particularly only two healthy controls — severely limits statistical power and generalizability, and the cross-sectional design allows association only, not causal inference. Findings have not been independently replicated.